Resveratrol represses YKL-40 expression in human glioma U87 cells.
Zhang
Wei
W
Department of Neurosurgery, Xijing Hospital, The Fourth Military Medical University, 127 West Changle Road, Xi'an, Shaanxi Province, 710032, People's Republic of China.
Murao
Koji
K
Zhang
Xiang
X
Matsumoto
Kensuke
K
Diah
Suwarni
S
Okada
Masaki
M
Miyake
Keisuke
K
Kawai
Nobuyuki
N
Fei
Zhou
Z
Tamiya
Takashi
T
D054392:Adipokines; D000972:Antineoplastic Agents, Phytogenic / Q000494:pharmacology; D001932:Brain Neoplasms / Q000188:drug therapy* / Q000378:metabolism; D045744:Cell Line, Tumor; D049109:Cell Proliferation; D002470:Cell Survival; D000071451:Chitinase-3-Like Protein 1; D003470:Culture Media / Q000378:metabolism; D018572:Disease-Free Survival; D015972:Gene Expression Regulation, Neoplastic; D005910:Glioma / Q000188:drug therapy* / Q000378:metabolism; D006023:Glycoproteins / Q000096:biosynthesis*; D006801:Humans; D037102:Lectins / Q000096:biosynthesis*; D011379:Prognosis; D011401:Promoter Regions, Genetic; D012008:Recurrence; D000077185:Resveratrol; D013267:Stilbenes / Q000494:pharmacology*
D054392:Adipokines; D000972:Antineoplastic Agents, Phytogenic; C084533:CHI3L1 protein, human; D000071451:Chitinase-3-Like Protein 1; D003470:Culture Media; D006023:Glycoproteins; D037102:Lectins; D013267:Stilbenes; D000077185:Resveratrol